Search

Your search keyword '"Hallgreen, Christine E."' showing total 38 results

Search Constraints

Start Over You searched for: Author "Hallgreen, Christine E." Remove constraint Author: "Hallgreen, Christine E."
38 results on '"Hallgreen, Christine E."'

Search Results

2. Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study

4. Mandatory requirements for pediatric drug development in the EU and the US for novel drugs-A comparative study

5. Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis

6. Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis

7. Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study

10. Mandatory requirements for pediatric drug development in the EU and the US for novel drugs:A comparative study

11. Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada:A Longitudinal Cohort Study

12. Guidance for pediatric use in prescription information for novel medicinal products in the EU and the US

13. Influence of drug safety advisories on drug utilisation:an international interrupted time series and meta-analysis

18. Benefit–risk assessment in a post-market setting: a case study integrating real-life experience into benefit–risk methodology†

21. Improving Interactions Between Health Technology Assessment Bodies and Regulatory Agencies: A Systematic Review and Cross-Sectional Survey on Processes, Progress, Outcomes, and Challenges

22. Improving Interactions Between Health Technology Assessment Bodies and Regulatory Agencies:A Systematic Review and Cross-Sectional Survey on Processes, Progress, Outcomes, and Challenges

28. The effectiveness of direct to healthcare professional communication: A systematic review of communication factor studies

32. Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology

33. Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

34. A comprehensive approach to benefit–risk assessment in drug development

36. Mandatory requirements for pediatric drug development in the EU and the US for novel drugs-A comparative study.

37. Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis.

Catalog

Books, media, physical & digital resources